A detailed history of Putnam Investments LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Putnam Investments LLC holds 1,210,735 shares of REGN stock, worth $865 Million. This represents 1.46% of its overall portfolio holdings.

Number of Shares
1,210,735
Previous 1,186,406 2.05%
Holding current value
$865 Million
Previous $976 Million 8.91%
% of portfolio
1.46%
Previous 1.53%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$775.18 - $881.7 $18.9 Million - $21.5 Million
24,329 Added 2.05%
1,210,735 $1.06 Billion
Q3 2023

Nov 14, 2023

BUY
$692.45 - $844.37 $11.8 Million - $14.4 Million
17,085 Added 1.46%
1,186,406 $976 Million
Q2 2023

Aug 14, 2023

BUY
$700.03 - $830.35 $2.8 Million - $3.32 Million
4,004 Added 0.34%
1,169,321 $840 Million
Q1 2023

May 22, 2023

BUY
$680.49 - $826.97 $32.5 Million - $39.5 Million
47,784 Added 4.28%
1,165,317 $958 Million
Q4 2022

Feb 14, 2023

BUY
$705.89 - $766.39 $9.67 Million - $10.5 Million
13,700 Added 1.24%
1,117,533 $806 Million
Q3 2022

Nov 14, 2022

SELL
$573.97 - $724.32 $4.4 Million - $5.56 Million
-7,670 Reduced 0.69%
1,103,833 $760 Million
Q2 2022

Aug 15, 2022

BUY
$548.35 - $738.84 $8.93 Million - $12 Million
16,292 Added 1.49%
1,111,503 $657 Million
Q1 2022

May 16, 2022

SELL
$595.12 - $698.43 $148 Million - $173 Million
-248,392 Reduced 18.49%
1,095,211 $765 Million
Q4 2021

Feb 14, 2022

BUY
$543.48 - $670.97 $461,414 - $569,653
849 Added 0.06%
1,343,603 $849 Million
Q3 2021

Nov 15, 2021

BUY
$574.03 - $680.96 $232 Million - $275 Million
404,567 Added 43.12%
1,342,754 $813 Million
Q2 2021

Aug 16, 2021

BUY
$472.8 - $558.54 $134 Million - $158 Million
282,535 Added 43.09%
938,187 $524 Million
Q1 2021

May 17, 2021

BUY
$446.73 - $548.2 $103 Million - $127 Million
231,463 Added 54.57%
655,652 $310 Million
Q4 2020

Feb 16, 2021

SELL
$478.3 - $607.98 $143 Million - $181 Million
-298,334 Reduced 41.29%
424,189 $205 Million
Q3 2020

Nov 16, 2020

BUY
$544.75 - $658.21 $13.1 Million - $15.8 Million
23,989 Added 3.43%
722,523 $404 Million
Q2 2020

Aug 14, 2020

BUY
$493.32 - $643.92 $12.1 Million - $15.8 Million
24,483 Added 3.63%
698,534 $436 Million
Q1 2020

May 15, 2020

BUY
$336.18 - $494.43 $66.4 Million - $97.6 Million
197,393 Added 41.41%
674,051 $329 Million
Q4 2019

Feb 14, 2020

BUY
$274.13 - $376.51 $130 Million - $179 Million
474,138 Added 18815.0%
476,658 $179 Million
Q3 2019

Nov 14, 2019

BUY
$273.46 - $318.39 $5,742 - $6,686
21 Added 0.84%
2,520 $699,000
Q2 2019

Aug 14, 2019

SELL
$299.6 - $414.82 $9.9 Million - $13.7 Million
-33,054 Reduced 92.97%
2,499 $782,000
Q1 2019

May 15, 2019

BUY
$372.08 - $439.57 $10.6 Million - $12.5 Million
28,548 Added 407.54%
35,553 $14.6 Million
Q4 2018

Feb 14, 2019

BUY
$335.82 - $403.04 $2.01 Million - $2.41 Million
5,986 Added 587.44%
7,005 $2.62 Million
Q3 2018

Nov 14, 2018

SELL
$351.14 - $408.51 $42,487 - $49,429
-121 Reduced 10.61%
1,019 $412,000
Q4 2017

Feb 14, 2018

SELL
$358.63 - $469.95 $80.5 Million - $106 Million
-224,510 Reduced 99.49%
1,140 $429,000
Q3 2017

Nov 14, 2017

BUY
$431.38 - $504.0 $97.3 Million - $114 Million
225,650
225,650 $101 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Putnam Investments LLC Portfolio

Follow Putnam Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.